FDA Approved: MAXIDEX — Supplemental Application (Harrow Eye, LLC)

View source ↗

Summary

The FDA approved a supplemental application for MAXIDEX (dexamethasone) from Harrow Eye, LLC, authorizing changes to the drug's labeling as part of an NDA updat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation
• Postoperative Ocular Inflammation

Drugs mentioned

• Maxidex (dexamethasone 0.1%)

Snippet

SUPPL AP for MAXIDEX (DEXAMETHASONE)